UOC
RAIN

UBS O'Connor’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

UBS O'Connor’s Portfolio RAIN Stock Details RAIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-67,842
Closed -$593K – 676
2023
Q1 		$593K Sell
67,842
-233,114
-77% -$2.16M 0.01% 451
2022
Q4 		$2.41M Sell
300,956
-25,495
-8% -$160K 0.04% 380
2022
Q3 		$1.59M Sell
326,451
-6,800
-2% -$42.7K 0.02% 680
2022
Q2 		$1.85M Buy
333,251
+244,981
+278% +$841K 0.02% 670
2022
Q1 		$448K Buy
+88,270
New +$708K ﹤0.01% 752

Other funds holding RAIN

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $295M AUM 40.98% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

UBS O'Connor's RAIN Position: Q2 2023 in Review

UBS O'Connor sold out of Rain Oncology Inc. Common Stock (RAIN) in Q2 2023, closing a stake of 67,842 shares — an estimated $593K sold.

UBS O'Connor first reported a position in RAIN in Q1 2022 and held it in 5 quarters. The position peaked at $2.41M in Q4 2022. 62 funds tracked by Wall St. Rank hold RAIN as of Q2 2023.

  • UBS O'Connor reported no remaining Rain Oncology Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • UBS O'Connor sold 67,842 Rain Oncology Inc. Common Stock shares in Q2 2023, an estimated $593K.
  • UBS O'Connor first reported a position in Rain Oncology Inc. Common Stock in Q1 2022 and held it in 5 quarters.
  • UBS O'Connor's Rain Oncology Inc. Common Stock position peaked at $2.41M in Q4 2022.
  • 62 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q2 2023.

Based on UBS O'Connor's 13F filing for Q2 2023, filed 14 Aug 2023.